(Reuters) - From COVID-19 to abortion and treatments for transgender youth, a look at states' initiatives to legislate drug use and how it may clash with federal law. Features Michelle Mello of Stanford Law and School of Medicine, Philip Katz of Hogan Lovells and Kyle Faget of Foley & Lardner. Our Standards: The Thomson Reuters Trust Principles. Alex Cohen produces multimedia projects on legal trends, key cases, and industry issues. He can be reached at alex.cohen@thomsonreuters.com. You can follow him on Twitter @alexlcohen.